The role of JAK/STAT pathway in fibrotic diseases: molecular and cellular mechanisms

J Liu, F Wang, F Luo - Biomolecules, 2023 - mdpi.com
There are four members of the JAK family and seven of the STAT family in mammals. The
JAK/STAT molecular pathway could be activated by broad hormones, cytokines, growth …

An overview of the inflammatory signalling mechanisms in the myocardium underlying the development of diabetic cardiomyopathy

G Frati, L Schirone, I Chimenti, D Yee… - Cardiovascular …, 2017 - academic.oup.com
Heart failure is a highly morbid and mortal clinical condition that represents the last stage of
most cardiovascular disorders. Diabetes is strongly associated with an increased incidence …

gp130 controls cardiomyocyte proliferation and heart regeneration

Y Li, J Feng, S Song, H Li, H Yang, B Zhou, Y Li… - Circulation, 2020 - Am Heart Assoc
Background: A key cause of the high mortality of cardiovascular diseases is the
cardiomyocyte inability to renew after cardiac injury. As a promising strategy to supplement …

Interleukin 6 mediates myocardial fibrosis, concentric hypertrophy, and diastolic dysfunction in rats

GC Meléndez, JL McLarty, SP Levick, Y Du… - …, 2010 - Am Heart Assoc
Although there is a correlation between hypertension and levels of interleukin (IL) 6, the
exact role this cytokine plays in myocardial remodeling is unknown. This is complicated by …

Contractile defect caused by mutation in MYBPC3 revealed under conditions optimized for human PSC-cardiomyocyte function

MJ Birket, MC Ribeiro, G Kosmidis, D Ward… - Cell reports, 2015 - cell.com
Maximizing baseline function of human pluripotent stem cell-derived cardiomyocytes (hPSC-
CMs) is essential for their effective application in models of cardiac toxicity and disease …

An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy

X Palomer, L Salvadó, E Barroso… - International journal of …, 2013 - Elsevier
Metabolic disorders such as obesity, insulin resistance and type 2 diabetes mellitus are all
linked to cardiovascular diseases such as cardiac hypertrophy and heart failure. Diabetic …

Survival pathways in hypertrophy and heart failure: the gp130-STAT3 axis

P Fischer, D Hilfiker-Kleiner - Basic research in cardiology, 2007 - Springer
Circulating levels of interleukin (IL)–6 and related cytokines are elevated in patients with
congestive heart failure and after myocardial infarction. Serum IL-6 concentrations are …

Cardiac fibroblast p38 MAPK: a critical regulator of myocardial remodeling

NA Turner, NM Blythe - Journal of cardiovascular development and …, 2019 - mdpi.com
The cardiac fibroblast is a remarkably versatile cell type that coordinates inflammatory,
fibrotic and hypertrophic responses in the heart through a complex array of intracellular and …

The p65 subunit of NF-κB binds to PGC-1α, linking inflammation and metabolic disturbances in cardiac cells

D Alvarez-Guardia, X Palomer, T Coll… - Cardiovascular …, 2010 - academic.oup.com
Aims Nuclear factor-κB (NF-κB) is a transcription factor induced by a wide range of stimuli,
including hyperglycaemia and pro-inflammatory cytokines. It is associated with cardiac …

The microenvironment of the pathogenesis of cardiac hypertrophy

F Bazgir, J Nau, S Nakhaei-Rad, E Amin, MJ Wolf… - Cells, 2023 - mdpi.com
Pathological cardiac hypertrophy is a key risk factor for the development of heart failure and
predisposes individuals to cardiac arrhythmia and sudden death. While physiological …